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Traditional treatment and altered auditory feedback lead to intelligibility benefits in a
subset of speakers with Parkinson disease1

Christopher Dromey (Commentary author), Department of Communication Disorders,
Brigham Young University, Provo, Utah, U.S.A.

Q
What are the effects of traditional rate control treatments and altered auditory feedback
(AAF) devices on the speaking rate and intelligibility of people with Parkinson disease
(PD)?
METHODS
Design: The authors reported using an alternating treatment design, although the
methodology involved aspects of an ABACA/ACABA design. Participants received each
type of intervention once, separated by a 6-week no treatment period. Performance was
measured before and after each treatment and also after 6 weeks and 6 months.

1

Abstracted from: Lowit, A., Dobinson, C., Timmins, C., Howell, P., & Kroeger, B.
(2010). The effectiveness of traditional methods and altered auditory feedback in
improving speech rate and intelligibility in speakers with Parkinson's disease.
International Journal of Speech Language Pathology, 12, 426-436.
For correspondence: dromey@byu.edu
Source of funding and disclosure of interests: Parkinson’s UK. No disclosures of interests
were reported.
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Allocation: Individuals were quasi-randomly assigned to receive one treatment or the
other first. They were alternately assigned as they entered the study.
Blinding: It is not reported whether the therapists providing the treatment were blind to
the study’s purpose. The individuals analyzing the acoustic data and judging
intelligibility were blind to the treatment condition and assessment time.
Study duration: The baseline assessments, two 6-week treatments, and follow-up
evaluations covered a 48-week period. Because participants did not all join the study at
the same time, the overall investigation was completed in 18 months.
Setting: Assessments and intervention sessions took place in quiet conditions in the
participants’ homes.
Participants: Six men and 4 women with idiopathic PD took part in the study. Exclusion
criteria included significant dementia or a history of deep brain stimulation or speech
therapy for dysarthria symptoms within the prior year.
Intervention: Two interventions were given; each was provided in hour-long sessions
once a week for 6 weeks. There was a 6 week period of no treatment between the two
interventions. Traditional therapy (TT) focused on rate reduction, with most participants
choosing pause insertion over stretching out articulation. Following a typical clinical
hierarchy, the participants moved from short phrases to conversational speech to practice
reducing their rate. Verbal feedback and audio recordings helped them develop selfmonitoring skills. Altered auditory feedback (AAF) relied on delayed and/or frequency
shifted feedback to achieve slower speech, with participants choosing one of two devices.
During the initial sessions the participants tried different feedback types and settings to
determine which would reduce rate most effectively with a minimal negative impact on
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naturalness. Since the effect of the device on rate was immediate in most cases, no further
attention was directed at slower speech. For both intervention types, additional treatment
was directed when necessary at other aspects of speech, such as intonation.
Outcomes: Speech rate was measured as the number of syllables spoken per second in a
reading passage. A second experimenter re-analyzed 10% of the data, which was
significantly correlated (r = .444) with the original measures. The reading passage was
judged for perceived intelligibility using direct magnitude estimation and the monologue
was evaluated with a 9-point Likert scale. Agreement between raters for the monologue
was high (intraclass correlation coefficient r =.89).
Attrition: All participants completed the study.
MAIN RESULTS
For the group, there were no statistically significant increases in intelligibility or
decreases in speech rate following either type of treatment. No significant differences
were found between the effects of the two treatment types. A comparison between AAF
and no feedback conditions showed that rate decreased while the feedback device was
active, but that intelligibility was not affected. Although no significant group effects were
found regardless of treatment type, 4 of the 10 participants improved in intelligibility
after the first treatment phase. These gains were maintained across the remaining
assessments, including at the 6-month follow-up. Three participants showed increased
intelligibility while the AAF device was in use during each of the assessments, but three
speakers showed no improvement from either intervention.
AUTHOR’S CONCLUSIONS
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A subset of individuals with PD may benefit from traditional therapy that targets reduced
speaking rate. Speakers who do not experience improvements may not be generalizing
therapy techniques to situations outside the clinic. AAF devices can lead to
improvements in speaking rate and intelligibility in about one third of the participants,
thus for some speakers this could be an effective treatment option. Improvements in
speech with AAF could not be trained during therapy, and thus the benefits seem limited
to those speakers who show an immediate, automatic response to the device. Habituation
to the device can lead to decreased benefits in some speakers, but minor adjustments to
the settings may restore AAF effectiveness. Some patients may find AAF unacceptable
because the more effective binaural devices are conspicuous. The diminutive size of the
controls can present problems for individuals with PD whose motor control is impaired.

Commentary
Because relatively little evidence has been published that compares the long-term effects
of different dysarthria treatments, the authors undertook a study to document changes in
speech rate and intelligibility in response to two types of intervention. Rate control is
taught in many speech-language pathology training programs as a means to improve
speech intelligibility, and thus it was a logical choice for the present study. Likewise,
AAF has been shown to impact both normal and disordered speech, in most cases
resulting in reduced rate. In theory, either approach should have a positive effect on
speech, since individuals with neuromotor control deficits would have more time to reach
their articulatory targets. However, as the authors of the present study noted, the
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relationship between speaking rate and intelligibility is not simple (Van Nuffelen, De
Bodt, Vanderwegen, Van de Heyning, & Wuyts, 2010).
Previous work (Tjaden & Wilding, 2004) has shown that reduced rate can
increase the acoustic distinctiveness of vowels, although improvements in scaled
intelligibility were not found. The speakers in the Tjaden and Wilding study were tested
on a single occasion as they altered their speaking rate at the request of the experimenter,
much like the simulated treatments reported by others (Dromey, 2000). In contrast, a
particularly valuable contribution of the present study was that speakers were recorded
before and after a course of intervention by a speech-language pathologist. This approach
involves substantially more work, but also yields results that are more valid in evaluating
the impact of the intervention. By assessing and treating the participants in their own
homes, the researchers further strengthened the ecological validity of their work, since
this setting is not atypical of service delivery in the United Kingdom.
In treating the participants’ dysarthria in a clinically representative way, the
authors may have introduced additional influences beyond the two main treatment effects
of slower rate and AAF. For example, by allowing the speakers to select either pause
insertion or syllable lengthening to achieve slower speech, or to select one of two AAF
devices, the external validity increased (since typical patients would likely be given this
option), but at the cost of adding the confounding variable of each participant’s treatment
preference to the main independent variable of rate adjustment versus AAF. Another area
where there may have been a trade-off in increasing external validity while potentially
reducing internal validity was where the authors noted that “where appropriate, other
speech aspects in need of treatment, such as volume or intonational variation” (p. 429)
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were also treated, and homework assignments were given that may have been completed
more diligently by some participants than by others. Since the listeners judged perceived
speech intelligibility, this overall rating could have been influenced by more than just rate
reduction or AAF. However, it should be stressed that the therapy was more reflective of
typical clinical practice as a result of this approach, which in the end is likely to be of
greater value to the article’s audience than the purity of the independent variable. On the
other hand, without strong internal validity, the desired external validity may be
compromised. The ABACA/ACABA design (Schlosser, 1999) of the present study
allowed potential order effects to be minimized for the treatment groups as a whole.
However, it did not allow this protection at the individual participant level in the same
way as a true alternating treatment design would. An alternating treatments design
involves the provision of two treatments that are alternated in rapid succession to allow
changes accompanying each approach to be graphed and compared (Wong, 2010).
The take-home message of this paper is that while not all participants in a
treatment group will show consistent and thus statistically significant changes in
intelligibility as a result of therapy, individual speakers with PD show evidence of
improvement from both traditional and AAF treatments. Inter-speaker variability is a
clinical and research reality in neurogenic communication disorders. Clinicians would be
well advised to undertake treatments that have been shown in the literature to positively
affect functional communication, adapting these interventions where necessary to
maximize individual benefits. Since both rate reduction and AAF can lead to
improvements in intelligibility for some speakers, in addition to the well-documented
effects of treatments like Lee Silverman Voice Treatment (Ramig, Fox, & Sapir, 2004),
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clinicians should consider a variety of therapy options, tailored to the circumstances of
the individual patient.

Declaration of interests. The commentary author has no conflicts of interests and is
solely responsible for the content of this structured abstract.
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